Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
University of Utah
Salt Lake City, Utah
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 646. We're showing you the first 500 records. If you need every record from this institution, you can download all of our data at the ProPublica Data Store.
Name | Type | Company | Disclosed Value | Year Filed |
---|---|---|---|---|
George Rodgers | Conflict of Interest | Bioverativ | $20,000-39,999 | 2012-2019 |
Gerald Krueger | Conflict of Interest | Johnson & Johnson | $20,000-39,999 | 2012-2019 |
Gerald Krueger | Conflict of Interest | Novartis | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000-39,999 | 2012-2019 |
Gerald Krueger | Conflict of Interest | Novartis | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000 - $39,999 | 2018 |
Christopher Peters | Conflict of Interest | Biomet | $20,000-39,999 | 2012-2019 |
Scott Summers | Conflict of Interest | Centaurus Therapeutics | $20,000-39,999 | 2012-2019 |
Scott Summers | Conflict of Interest | Centaurus Therapeutics | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000-39,999 | 2012-2019 |
Christopher Pelt | Conflict of Interest | Biomet | $20,000-39,999 | 2012-2019 |
Jiyuan Yang | Conflict of Interest | TheraTarget | $20,000-39,999 | 2012-2019 |
George Rodgers | Conflict of Interest | Bioverativ | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000-39,999 | 2012-2019 |
Gerald Krueger | Conflict of Interest | Abbott Pharmacutical | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000-39,999 | 2012-2019 |
Edward Dudek | Conflict of Interest | Epitel | $20,000-39,999 | 2012-2019 |
Gerald Krueger | Conflict of Interest | Novartis | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000-39,999 | 2012-2019 |
George Rodgers | Conflict of Interest | Bioverativ | $20,000-39,999 | 2012-2019 |
K-T Varley | Conflict of Interest | Kailos Genetics | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics (Omicia) | $20,000-39,999 | 2012-2019 |
Loren Rieth | Conflict of Interest | Blackrock Microsystems | $20,000-39,999 | 2012-2019 |
Edward Dudek | Conflict of Interest | Epitel | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000-39,999 | 2012-2019 |
Gerald Krueger | Conflict of Interest | Janssen Pharmaceutical Inc | $20,000-39,999 | 2012-2019 |
Prashant Tathireddy | Conflict of Interest | Blackrock Microsystems | $20,000-39,999 | 2012-2019 |
Christopher Peters | Conflict of Interest | Biomet | $20,000-39,999 | 2012-2019 |
Loren Rieth | Conflict of Interest | Blackrock Microsystems | $20,000-39,999 | 2012-2019 |
Terry Box | Conflict of Interest | Gilead | $20,000-39,999 | 2012-2019 |
K-T Varley | Conflict of Interest | Kailos Genetics | $20,000-39,999 | 2012-2019 |
Loren Rieth | Conflict of Interest | Blackrock Microsystems | $20,000-39,999 | 2012-2019 |
Gerald Krueger | Conflict of Interest | Novartis | $20,000-39,999 | 2012-2019 |
Christopher Pelt | Conflict of Interest | Biomet | $20,000-39,999 | 2012-2019 |
Christopher Peters | Conflict of Interest | Biomet | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Omcia | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Omcia | $20,000-39,999 | 2012-2019 |
Christopher Peters | Conflict of Interest | Biomet | $20,000-39,999 | 2012-2019 |
Gerald Krueger | Conflict of Interest | Novartis | $20,000-39,999 | 2012-2019 |
Gerald Krueger | Conflict of Interest | Centocor | $20,000-39,999 | 2012-2019 |
Luke Simon | Conflict of Interest | N/A | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000-39,999 | 2012-2019 |
Mark Yandell | Conflict of Interest | Fabric Genomics | $20,000 - $39,999 | 2018 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.